Benzinga(@Benzinga):Kodiak Sciences ($KOD) says Zenkuda and tabirafusp-ted matched Regeneron’s ($REGN) Eylea in a Phase 3 wet AMD trial. Zenkuda also showed durable vision gains, with 54% of patients maintaining improvement for six months.

Benzinga

@Benzinga

Financial News, Data & Education 💸

Joined June 2009

849 Following 343.9K Followers

Benzinga@Benzinga

2026.09.28 17:01

Kodiak Sciences ($KOD) says Zenkuda and tabirafusp-ted matched Regeneron’s ($REGN) Eylea in a Phase 3 wet AMD trial. Zenkuda also showed durable vision gains, with 54% of patients maintaining improvement for six months.

Forward to community

Most Popular Users

758.4K Followers

111.9M Followers

1M Followers

241.7M Followers

6.3M Followers

197K Followers

3.4M Followers

5.4M Followers

4.2M Followers

2M Followers

471.4K Followers

1.8M Followers

349.1K Followers

2.1M Followers

568.8K Followers